Mechanism of eosinophilia. 3. Suppression of eosinophilia by agents known to modify immune responses.
D000818:Animals; D002066:Busulfan / Q000627:therapeutic use; D003352:Corynebacterium; D003520:Cyclophosphamide / Q000627:therapeutic use; D004731:Endotoxins / Q000627:therapeutic use; D004802:Eosinophilia / Q000209:etiology / Q000276:immunology* / Q000517:prevention & control; D004804:Eosinophils; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007958:Leukocyte Count; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D010567:Pertussis Vaccine / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D051381:Rats; D014234:Trichinella
D004731:Endotoxins; D007166:Immunosuppressive Agents; D010567:Pertussis Vaccine; D003520:Cyclophosphamide; D011239:Prednisolone; D002066:Busulfan; D008727:Methotrexate